* * DEMOGRAPHICS DRAWN FROM PATHOLOGY REPORT * * PATIENT :    LEGATE , PENNY SUE MRN :        U5891485      ( UWMC ) DOB :        Feb   5 1955 SEX :        F . 
CASE :    SU-16 - 06910    COLLECTED :   Mar 16 2016   RECEIVED : Mar 16 2016 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ FINAL DIAGNOSIS : E )   Left breast , nipple - sparing mastectomy : 1 . 
Invasive ductal carcinoma , see summary cancer data below . 
2 . 
Background breast with fibrocystic changes , apocrine metaplasia , and biopsy site changes . 
A )   Right breast , excisional biopsy : 1 . 
Breast parenchyma with biopsy site changes . 2 . 
Focal atypical lobular hyperplasia . 3 . 
No in - situ or invasive carcinoma identified . 
B , C )   Left axillary sentinel lymph nodes # 1 and # 2 , excisions : 1 . 
Two lymph nodes with no neoplasm identified . 2 . 
Biopsy site changes . 
D )   Left breast nipple margin , excision : Breast parenchyma with no neoplasm identified . 
SUMMARY CANCER DATA : Specimen and procedure Procedure :     Nipple - sparing mastectomy Specimen laterality :     Left Primary tumor ( status post pre - surgical therapy ) Residual invasive carcinoma S / P neoadjuvant therapy Histologic type :     Invasive ductal carcinoma , NOS ( 85003 ) Extent / focality of carcinoma :     Single contiguous residual mass / focus Span of residual invasive carcinoma ( tumor bed ) :     1.2 cm    x 1.2 cm Size of largest residual focus of carcinoma :     1.2 cm Overall cellularity ( invasive carcinoma only ) :     70% Grade of residual carcinoma :     Deferred because of prior therapy Skin status :     Can not assess ( skin not present ) Nipple status :     Can not assess ( nipple not present ) Skeletal muscle status :     Skeletal muscle not present Pre - treatment tumor characteristics Pre - treatment Nottingham grade :     Grade III : 8 - 9 points Pre - treatment ER :     Negative ( Allred 
< = 2 ) Pre - treatment PR :     Negative Pre - treatment her 2 by IHC :     Positive for her 2 overexpression by immunohistochemistry Pre - treatment Ki-67 :     60% Additional findings DCIS ( ductal carcinoma in situ ) :     Residual DCIS present ( 85002 ) Nuclear grade of DCIS :     High Necrosis in DCIS : Present and central ( expansive " comedo " necrosis ) Distance spanned by DCIS :     1.2 cm Comment about DCIS : The invasive carcinoma arises within a background of high grade DCIS with comedo necrosis . Microcalcifications :     Present in DCIS Present in invasive carcinoma Final surgical resection margins ( including separately submitted margins ) : Invasive carcinoma margins :     Invasive carcinoma < 0.2 cm from at least one inked margin Invasive carcinoma margin detail : Invasive carcinoma is < 0.1 cm from the superior superficial margin and 0.8 cm from the posterior margin . 
Invasive carcinoma is > 1.0 cm from all other margins . 
DCIS margin :     DCIS > = 0.2 cm and < 0.5 cm from at least one margin DCIS margin detail : DCIS is 0.3 cm from the superior superficial margin and 0.4 cm   from the posterior margin . 
DCIS is > 1.0 cm from all other margins . 
Lymph node involvement ( S / P neoadjuvant therapy ) Non - sentinel nodes :     Non - SLNs with carcinoma : 0     / Total non - SLNs 0 Sentinel lymph nodes :     SLNs with carcinoma : 0     / Total SLNs : 2 - Total number of nodes with macrometastases :     0 - Total number of nodes with micrometastases :     0 - Total number of nodes with isolated tumor cells :     0 Evidence of nodal treatment response :     No definite treatment response Comment about nodal treatment response : Hemosiderin - laden macrophages and fibrosis are present in left axillary sentinel lymph node # 1 consistent with biopsy site . 
Minimum pathologic stage ( AJCC , 7th ed . , 2010 ) Primary tumor [ pT ] :     ypT1c : Tumor > 1.0 cm and < = 2.0 cm - greatest dimension Regional nodes [ pN ] :     ypN0 : No regional lymph node metastasis histologically ( ITCs may be present ) _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ INTRAOPERATIVE CONSULTATION : BCFS )    Atypical cells - fibrosis / hemorrhage present in part B consistent with treatment effect / biopsy site .   
No definite carcinoma identified .   
Favor macrophages .   
( Mara Rendi , M.D./Colin Murphy , M.D./Suzanne Dintzis , M.D. )   ( SR / pwt ) CLINICAL DATA : Left breast cancer GROSS DESCRIPTION : A )     Received :   Fresh in a container designated " Penny Legate " and " A. right breast excisional biopsy " Specimen type :   Excisional biopsy Formalin time :   March 17th 7:20 a.m. Tissue obtained for tumor banking : No Weight :   5 g Size :   3.1 ( ML ) x 2.8 ( SI ) x 1.0 ( AP ) cm Oriented With :   Short stitch superior and long stitch lateral Ink :   Per protocol by the surgeon :   superior = red , inferior = blue , anterior = green , posterior = black , medial = yellow , lateral = orange Sectioning :   Medial to lateral in four sections of 0.4 cm average thickness with 1.0 cm ends Findings :   No lesion , the breast parenchyma is variably firm with yellow lobulated adipose tissue with clip discovered in slice 3 Cassettes submitted : A1 , A2 - medial slice 4 A3 - slice 3 A4 - slice 2 A5 , A6 - lateral slice 1 entirely submitted Total fixation time : 10 hours , 40 minutes ( NR / clk ) B )     Received fresh in a container for frozen labeled " Legate , Penny Sue , left axillary sentinel lymph node # 1 " is a 3 x 1.5 x 2 cm fatty lymph node .   
A representative section of the lymph node is inked blue and submitted for frozen .   
The frozen section residue is submitted in BCFS1 .   
The remaining lymph node is submitted in cassettes B2-B4 .   
( SR / pwt ) C )     Received fresh in a container for frozen labeled " Legate , Penny Sue , left axillary sentinel lymph node # 2 " is a 1.5 x 1.0 x 0.5 cm fatty congested lymph node candidate .   
The specimen is bisected and one half is inked orange and submitted for frozen .   
The frozen section residue is submitted in BCFS1 .   
The remaining lymph node is submitted in C2 .   
( SR / pwt ) D )     Received in a container of formalin labeled " Legate , Penny Sue , left breast nipple margin " is a nonoriented 1.6 x 1.0 x 0.5 cm tan rubbery portion of tissue .   
The margins are inked blue and there are unremarkable cut surfaces .   
The specimen is entirely submitted in cassette D1 .   ( SR / pwt ) 
E )     Received :   Fresh in a container designated " Legate , Penny " and " E. left breast " Specimen type :   Nipple - sparing mastectomy Formalin time :   1630 March 16th Tissue obtained for tumor banking : No Weight :   155 g 
Overall size :   16.0 ( SI ) x 14.0 ( ML ) x 1.6 ( AP ) cm Axillary tail :   Not included Skin :   Not included Nipple and Areola : No nipple and areola identified , likely subareolar area inked yellow Ink :   Per protocol , deep = black , superior superficial = orange , inferior superficial = blue , subareolar = yellow Sectioning :   Medial to lateral into seventeen slices of 0.5 cm average thickness Findings :   Lesion # 1 :   Upper outer quadrant Location : 4.0 cm from the likely subareolar area Size : 1.2 x 1.0 x 0.8 cm Distance to deep margin : 1.2 cm Distance to superior superficial margin :   0.2 cm Distance to inferior superficial margin :   2.0 cm Evidence of prior biopsy or procedure :   Clip within cellulose identified Submitted :   Entirely Background breast :   65% unremarkable yellow , lobulated tissue with intervening white , fibrous bands Axillary tail :   Not identified Submitted :   Representative sections are submitted as follows : E1 , E2 - lesion entirely submitted E3 - sections immediately superior and inferior to mass E4 - section medial to mass E5 - section lateral to mass E6 - lower outer quadrant E7 - upper inner quadrant E8 - lower inner quadrant E9 - subareolar Total fixation time : 25 hours , 30 minutes ( NR / clk ) Nicholas   Reder MD , MPH AP / CP Resident 03/21/2016 Rochelle L Garcia MD Pathologist Electronically signed 
03/21/2016 In compliance with CMS regulations , the pathologist 's signature on this report indicates that the case has been personally reviewed , and the diagnosis made or confirmed by , the Attending Pathologist . 
Microscopic examination was used to arrive at the diagnosis unless indicated otherwise . 
